Alagebrium

alagebrium · Synvista Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Alagebrium, covering 2009-01-30 to 2020-08-07. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart [Phase 2]